Tuesday 23 April is World Table Tennis Day, a celebration of all things table tennis. We spoke to members of the Parkinson's community about their experiences of playing table tennis and how it helps them to manage their symptoms.
The TOP HAT trial is closing early and we have an important update on next steps.
Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Reach Your Peak is working with Parkinson's UK to deliver new hybrid workouts for people with Parkinson's.
Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital
The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
In a move designed to combat welfare benefit fraud and error, the UK government wants the power to instruct banks to provide details of their customer's accounts, even where there is no suspicion of fraud.
Patient groups, healthcare professionals and NHS England came together to take action to ensure people in hospital get their medication on time, every time.
We’re teaming up with Walking Football Scotland to give people with Parkinson's more opportunities to play the game.
The Prescription Charges Coalition have handed in a letter signed by over 600 people to freeze the charge at a time when costs are going up.
Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson’s who experience movement related symptoms.
Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson’s who experience movement related symptoms.
Produodopa, a groundbreaking new treatment for advanced Parkinson’s, can now be prescribed in Scotland.
Friday 8 March is International Women's Day and Parkinson's UK is celebrating all the inspirational women who either help to deliver our physical activity programmes, or have become physical activity advocates with Parkinson's.
This week’s spring budget failed to offer much-needed support for people with Parkinson’s.